Back to Peptides
Hormone FDA Approved

Dasiglucagon

A glucagon analog approved in the United States as Zegalogue for severe hypoglycemia.

Glucagon AnalogFDA ApprovedHypoglycemiaMetabolic

Also referenced as: Zegalogue

Status
FDA Approved

This peptide maps to at least one regulated medical product or label context in the United States.

Category
Hormone

This profile is grouped by its dominant research and market lane, not by vendor shelf placement.

Aliases
1

Zegalogue

Signal depth
Medium

FDA label signal · 21 trials · 0 PubMed results

What dasiglucagon is

Dasiglucagon is a glucagon analog approved in the United States as Zegalogue.

Why it matters

It adds a very real peptide-drug example from metabolic medicine and helps balance a library that can otherwise skew too heavily toward weight-loss signaling alone.

Regulatory context

Dasiglucagon is FDA approved in the United States.

Practical reading note

Approved glucagon-pathway drugs deserve a place in the library because they show how broad peptide pharmacology actually is in clinical medicine.